feedback

Course Director

Richard H. Sterns
Richard H. Sterns, MD

University of Rochester School of Medicine and Dentistry
Rochester, New York

Faculty

Tomas Berl
Tomas Berl, MD

University of Colorado School of Medicine
Aurora, Colorado

Paul Martin
Paul Martin, MD

University of Miami School of Medicine
Miami, Florida

Accredited by

Purdue University College of Pharmacy

Activity Details

Credit Types:CME / CPE / CNE
Credit Amount:0.5 Credits
Release Date:2011-Feb-25
Estimated Time for Completion:30 minutes
Registration Required:No
Cost:Free

Program Description & Educational Objectives

In this activity, a panel of experts in cirrhosis and hyponatremia discusses the pathogenesis and clinical implications of hypervolemic hyponatremia in patients with cirrhosis. The panel also discusses the current standard of care for hyponatremia in cirrhosis, and applies this standard to patient scenarios.

Upon completion of this activity, participants will be able to:

  • Explain the role of arginine vasopressin in the pathogenesis of hypervolemic hyponatremia in patients with cirrhosis
  • Apply evidence-based guidelines on the relative efficacy and safety of therapy for hypervolemic hyponatremia to point-of-care practice
  • Develop strategies for managing hypervolemic hyponatremia in cirrhosis in a variety of patient scenarios, including transplantation and hepatic encephalopathy

Target Audience

This activity has been designed to meet the educational needs of US-based gastroenterologists, hepatologists, physician assistants, nurse practitioners, and hospital pharmacists, as well as other clinicians involved in the care of patients with cirrhosis and hyponatremia.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/CNE/CPE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Internet
Release and Expiration Dates: February 25, 2011 - February 24, 2012
Time to Complete: 30 minutes

Faculty & Disclosure / Conflict of Interest Policy

All faculty AND staff involved in the planning or presentation of continuing education activities sponsored/provided by Purdue University College of Pharmacy are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

Course Director and Moderator

Richard H. Sterns, MD
Professor of Medicine
University of Rochester School of Medicine and Dentistry
Rochester, New York

Richard H. Sterns, MD, has a financial interest/relationship or affiliation in the form of:
Honoraria from Astellas Pharma US, Inc. and Otsuka Pharmaceutical Co., Ltd.

Interviewees

Tomas Berl, MD
Professor of Medicine
University of Colorado School of Medicine
Aurora, Colorado

Tomas Berl, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Otsuka Pharmaceutical Co., Ltd.
Speakers Bureau participant with Otsuka Pharmaceutical Co., Ltd.
Advisory Board for AstraZeneca LP.

Paul Martin, MD
Professor of Medicine
Chief, Division of Hepatology, Center for Liver Disease
University of Miami School of Medicine
Miami, Florida

Paul Martin, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Bristol-Myers Squibb Company and Salix Pharmaceuticals, Inc.
Grant/Research Support from Bristol-Myers Squibb Company; Genentech, Inc.; and Gilead.
Speakers Bureau participant with Bristol-Myers Squibb Company and Salix Pharmaceuticals, Inc.
Advisory Board for Bristol-Myers Squibb Company and Salix Pharmaceuticals, Inc.

Content Director

Annette Wiggins
PVI, PeerView Institute for Medical Education Annette Wiggins currently has no financial interests/relationships or affiliations in relation to this activity.

All additional planning committee members, PVI, PeerView Institute for Medical Education, Inc. staff, and Purdue University College of Pharmacy staff have no relationships to disclose.

Sponsorship, Credit & Support

Physicians

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Purdue University College of Pharmacy and PVI, PeerView Institute for Medical Education. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

Purdue University College of Pharmacy designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses

Purdue University Continuing Nursing Education (CNEP-09, 06/01/2011) is an approved provider of continuing nursing education by the Indiana State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity has been approved for 0.5 contact hour(s).

Note: Not all state nursing boards will accept programs less than 1.0 hour in length for credit. Please click here to find out the status of your state.

Pharmacists

Accreditation Council for Pharmacy Education Purdue University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge-based, continuing education activity of Purdue University, an equal access/equal opportunity institution. Universal Activity Number (UAN): 0018-9999-11-009-H01-P, 0.5 contact hours (0.05 CEUs).
Release Date: February 25, 2011 Expiration Date: February 24, 2012

This CME/CNE/CPE activity is jointly sponsored by Purdue University College of Pharmacy and PVI, PeerView Institute for Medical Education.

This activity is supported by an educational grant from Otsuka America Pharmaceutical, Inc.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.